Digital Content 
NEWS #PharmaBuzz
03 Apr 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/biosimilar-competition-looming-roche-takes-hit-failure-high-dose-ocrevus
02 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250402207576/en/Genentech-Provides-Update-on-Phase-III-Ocrevus-High-Dose-Study-in-People-With-Relapsing-Multiple-Sclerosis
13 Sep 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761371
13 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/halozyme-announces-fda-approval-of-roches-subcutaneous-ocrevus-zunovo-with-enhanze-for-people-with-relapsing-and-primary-progressive-multiple-sclerosis-302247928.html
12 Jul 2024
// Robert Barrie PHARMACEUTICAL-TECHNOLOGY
https://www.pharmaceutical-technology.com/news/nhs-rolls-out-more-convenient-ocrevus-injection-for-multiple-sclerosis/
21 Jun 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761053
Share 